Search filters

List of works by Jeffrey T Guptill

A Phase 1 Randomized Study of Single Intravenous Infusions of the Novel Nitroxyl Donor BMS-986231 in Healthy Volunteers

article

A Population-Based Pharmacokinetic Model Approach to Pantoprazole Dosing for Obese Children and Adolescents

scientific article published on 01 October 2018

A Retrospective study of complications of therapeutic plasma exchange in myasthenia ⬇️

scientific article published on November 21, 2012

A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal Transplantation

scientific article published on February 2017

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

scientific article published on 07 December 2020

Adaptive immune response to therapy in hmgcr autoantibody myopathy

scientific article published on 22 October 2015

Anti‐musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts ⬇️

scientific article published on July 1, 2011

Assessment of the effects of lacosamide on sleep parameters in healthy subjects

scientific article published on 25 October 2014

B cells in the pathophysiology of myasthenia gravis

scientific article

B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease Severity

scientific article published on 10 February 2017

Characterization of B cells in muscle-specific kinase antibody myasthenia gravis

scientific article

Circulating microRNA plasma profile in MuSK+ myasthenia gravis

scientific article published on 06 October 2018

Clinical outcome measures following plasma exchange for MG exacerbation

scientific article published on 27 September 2019

Comparative effectiveness clinical trials to advance treatment of myasthenia gravis

scientific article

Construction and validation of the chronic acquired polyneuropathy patient-reported index (CAP-PRI): A disease-specific, health-related quality-of-life instrument

scientific article

Cost analysis of myasthenia gravis from a large U.S. insurance database ⬇️

scientific article published on December 1, 2011

Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis

scientific article

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine

scientific article

Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.

scientific article published on 11 August 2016

Emerging Subspecialties in Neurology: Clinical development ⬇️

scientific article published on January 1, 2013

Establishment of normative ranges of the healthy human immune system with comprehensive polychromatic flow cytometry profiling

scientific article published on 11 December 2019

First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers

scientific article published on 07 April 2020

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

scientific article published on 25 March 2020

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

scientific article published on 17 October 2019

Inhibition of the transcription factor ROR-γ reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravis

scientific article published on 12 December 2019

International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r

scientific article

Marked clinical and jitter improvement after eculizumab in refractory myasthenia.

scientific article published on 18 February 2017

Myasthenia gravis and Lambert-Eaton myasthenic syndrome

scientific article

Obese Children Require Lower Doses of Pantoprazole Than Nonobese Peers to Achieve Equal Systemic Drug Exposures

scientific article published in February 2018

Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy

scientific article published on 2 May 2014

Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications

scientific article

Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects

scientific article published on 19 December 2016

Population Pharmacokinetics and Exploratory Exposure-Response Relationships of Diazepam in Children Treated for Status Epilepticus

scientific article published on 28 September 2018

Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus

scientific article published on 9 December 2016

Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia

scientific article published on 17 June 2017

Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment

scientific article

Recommendations for myasthenia gravis clinical trials

scientific article published on June 2012

Reliability of the triple-timed up-and-go test

scientific article published on 6 June 2017

Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes

scientific article published on 02 April 2013

Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant Patients

scientific article

Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach.

scientific article published on 12 July 2016

Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US

Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis

scientific article published on October 2010

Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine.

scientific article

Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI

Validation of the triple timed up-and-go test in Lambert-Eaton myasthenia

scientific article published on 18 July 2019

Paulina is supported by:

About Paulina

Help